Here, we investigated the impact of ART initiation timing on the intestinal B-cell antibody repertoires by studying IgG+ and IgA+ memory B cells and plasma cells from rectosigmoid colon tissues of individuals treated during the acute (eART) and chronic (lART) phases of infection. Here, CD79A is linked to infection.